NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Intraindividual variability of plasma antioxidants, markers of oxidative stress, C-reactive protein, cotinine, and other biomarkers.

Author(s): Block G, Dietrich M, Norkus E, Jensen C, Benowitz NL, Morrow JD, Hudes M, Packer L

Publication: Epidemiology, 2006, Vol. 17, Page 404-12

PubMed ID: 16755268 PubMed Review Paper? No

Suggested by: ISBER


Purpose of Paper

The purpose of this paper was to determine the effects of patient age, body mass index (BMI), smoking status and gender on the variability of plasma analytes.

Conclusion of Paper

Most analytes were changed by less than 10% between blood draws. However, alpha carotene varied by 22%, gamma tocopherol varied by 14% and cotinine varied by 24%, but only in those patients exposed to second hand smoke. The number of draws necessary for each analyte was dependent on patient age and smoking status. The required number of blood draws was not dependent on BMI or gender. The authors note that single outliers may have altered the outcome for some analytes.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of patient age, BMI, smoking status and gender on the variability of plasma analytes. Two blood draws were obtained 2-4 weeks apart from smokers and non-smokers exposed to second hand smoke.

    Summary of Findings:

    Most analytes were changed by less than 10% between blood draws. However, alpha carotene varied by 22%, gamma tocopherol varieed by 14% and cotinine varied by 24% but only in those patients exposed to second hand smoke. The number of draws necessary for each analyte was dependent on patient age and smoking status. The required number of blood draws was not dependent on BMI or gender. The authors note that single outliers may have altered the outcome for some analytes.

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Not specified
    Platform:
    AnalyteTechnology Platform
    Steroid Clinical chemistry/auto analyzer
    Small molecule GC-MS
    Small molecule Colorimetric assay
    Small molecule HPLC
    Lipid Clinical chemistry/auto analyzer
    Protein Radioimmunoassay
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Preaquisition Patient age Less than 45
    More than 45
    Preaquisition Patient gender Female
    Male
    Preaquisition Other drugs Smoker
    Non-smokers exposed to second hand smoke
    Biospecimen Aliquots and Components Aliquot sequential collection 1st collection
    2nd collection
    Preaquisition Diagnosis/ patient condition Body mass index less than 27.1
    Body mass index greater than 27.1

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...